This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
Showing 40 to 60 of 91 Results
Kasari C. L. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(5), pp. 487-495.
King B. H. et al. (2001)
Journal of the American Academy of Child and Adolescent Psychiatry
40(6), pp. 658-665
Kolmen B. K. et al. (1995)
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
Journal of the American Academy of Child and Adolescent Psychiatry
34(2), pp. 223-231
Kolmen B. K. et al. (1997)
Naltrexone in young autistic children: replication study and learning measures.
Journal of the American Academy of Child and Adolescent Psychiatry
36(11), pp. 1570-1578
Infantile autism with speech loss before the age of thirty months.
Journal of the American Academy of Child and Adolescent Psychiatry
24(2), pp. 191-196.
Lowe T. L. et al. (1981)
Folic acid and B12 in autism and neuropsychiatric disturbances of childhood.
Journal of the American Academy of Child and Adolescent Psychiatry
20(1), pp. 104-111
Mahoney W. et al. (1998)
Reliability and accuracy of differentiating pervasive developmental disorder subtypes.
Journal of the American Academy of Child and Adolescent Psychiatry
37(3), pp. 278-285
Malek-Ahmadi P. , Simonds J. (1998)
Olanzapine for autistic disorder with hyperactivity.
Journal of the American Academy of Child and Adolescent Psychiatry
September, 37(9), pp. 902
Malone R. P. et al. (2001)
Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.
Journal of the American Academy of Child and Adolescent Psychiatry
40 pp. 887-894.
Malone R. P. et al. (2002)
Journal of the American Academy of Child and Adolescent Psychiatry
41(2), pp. 140-147
Marcus R. N. et al. (2009)
Journal of the American Academy of Child and Adolescent Psychiatry
48(11), pp. 1110-1119
Open trial of risperidone in 24 young children with pervasive developmental disorders.
Journal of the American Academy of Child and Adolescent Psychiatry
40(10), pp. 1206-1214
Mazefsky C. A. et al. (2013)
The role of emotion regulation in autism spectrum disorder.
Journal of the American Academy of Child and Adolescent Psychiatry
52(7), pp. 679-688.
McDougle C. J. , Kem D. , Posey D. J. (2002)
Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
Journal of the American Academy of Child and Adolescent Psychiatry
41(8), pp. 921-927
McDougle C. J. et al. (1992)
Clomipramine in autism: preliminary evidence of efficacy.
Journal of the American Academy of Child and Adolescent Psychiatry
31(4), pp. 746-750.
McDougle C. J. et al. (1997)
Journal of the American Academy of Child and Adolescent Psychiatry
36 pp. 685-693
McGuire K. et al. (2015)
Journal of the American Academy of Child and Adolescent Psychiatry
December, 54(12), pp. 969-971.
Nicolson R. , Awad G. A. , Sloman L. (1998)
An open trial of risperidone in young autistic children.
Journal of the American Academy of Child and Adolescent Psychiatry
37(4), pp. 372-376
Olsson N. C. et al. (2017)
Journal of the American Academy of Child and Adolescent Psychiatry
July, 56(7), pp. 585–592.
An open-label trial of escitalopram in pervasive developmental disorders.
Journal of the American Academy of Child and Adolescent Psychiatry
44(4), pp. 343-348